Pune-based Hi Tech Biosciences, a research and development company engaged in the field of biotechnology, pharmaceuticals and agriculture has formed a joint venture with Holista CollTech Limited, Australia’s leading manufacturer of natural health supplements. Equinox Herbals Private Limited is the new 60:40 joint venture company, which will develop, patent and commercialise herbal products for various applications worldwide.
An agreement to this effect was signed today between the two companies by Raghavendra Gaikaiwari, CMD, Hi Tech Biosciences and M Rajen, CEO, Holista CollTech Limited. The work for the new plant has already begun and it is expected to be completed in 6 months time. Investments worth Rs 18 crore shall be made in setting up the plant.
"Though Indian herbs have been is use for thousands of years in traditional Ayurvedic medicine, its acceptance in the international market has been low due to lack of substantial documentation, distribution channels and acceptance by health authorities. This JV aims to develop herbal products that are backed by extensive scientific documentation, which would meet the most stringent requirements of various regulatory authorities", said Raghavendra Gaikaiwari, CMD, Hi Tech Biosciences .
M Rajen said, "The JV will leverage on Hi Tech’s research and development capabilities to develop and manufacture the world class herbal products in India with strict quality control and Holista would market these products globally, since it already has large customer base and access to over 1700 distribution points worldwide, providing ready outlets for JV’s products." According to Rajan, the market size is of this business is USD 90 billion and is dominated by Europe and China. India has very limited contribution in this. “The JV will primarily focus upon two areas including the registration and marketing of herbal formulations for various specialised applications such as diabetes and arthritis and in producing the standardised, extensively documented extracts from the Indian as well as the Malaysian herbs", Rajen added.
The JV will start functioning from the existing infrastructure of Hi Tech Biosciences. An all new manufacturing plant shall also be set under this joint venture at Supa village in Ahmednagar district, adjacent to the current plant of Hi Tech Biosciences, where active pharmaceuticals intermediates are manufactured.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
